When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.
Read More
5 current trends that will shape the life sciences in 2021 and beyond
Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.
Read More
5 questions to ask when designing oligonucleotide facilities
As industry momentum continues, oligonucleotide manufacturers are making the leap from benchtop production to commercial scale. The challenges of large-scale oligo manufacturing, however, are exponential in comparison to small scale, lab-based operations.
Read More
Precision medicine diagnostics are driving the need for flexible facility design
Precision medicine is based on the idea that each of us is different and may not react the same way to a particular treatment.
Read More
4 strategies to help your facility respond to the changing animal health market
The animal health market is changing. These four strategies will help your facility change with it.
Read More
Behind every rapid response is a strong regulatory strategy
During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.
Read More
Oral solid dosage manufacturing
Oral solid dosage (OSD) products can take several different shapes, and with those different forms comes different production techniques and facility designs. Here’s what is involved with manufacturing an orally-ingested drug product.
Read More
The basics and the process of drug approval
The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?
Read More
Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
Read More
Developing new tools in the pandemic response toolbox
There’s a lot to be learned from the COVID-19 pandemic, including how we can be better prepared for future pandemics.
Read More